$43 Million Invested Into Origami Owl

 
Gauge Capital has closed its first round of funding after raising $250 million.
The money, which exceeded Gauge’s fundraising goals, was accumulated through more than 15 investors, including endowments, institutional investors and CEOs. Co-founder and managing partnerDrew Johnson said he and his partners at Gauge made the most significant contributions to the fund.
With the cash, Gauge plans to invest in the food services, healthcare and business and consumer services sectors. Businesses must have $5 million to $50 million in earnings before interest, depreciation, taxes and amortization, or EBIDTA. Gauge then makes investments of $10 million to $50 million in each company.

“Our goal has been to find companies in those sectors, make investments and generate exceptional returns,” Johnson said.

Gauge already has made a $43 million investment out of the fund in Origami Owl, a company that allows individuals to sell their own jewelry. Three additional investments are around the corner.
“We have one under letter of intent in the healthcare services space,” Johnson said, but added that he can’t give details yet.
 
About Origami Owl 
Origami Owl® Custom Jewelry began in 2010 when 14-year-old Founder Bella Weems had a simple dream of owning a car by the time she turned sixteen.  She created a line of

Read more...

Innutra Expands In European Union

 
Innutra LLC announced the long awaited expansion and opening of the European Union for the Innutra products and opportunity.  They have products on the ground in our warehouse in Europe, and they are in a final stage of  the extensive process to certify, register and sell their products in all 28 EU countries.
 

Innutra’s expansion into the EU provides the company with an excellent opportunity for growth.  “We are very excited that Innutra products and systems are going to be available to help the millions of people in need of better health in the EU.” said co-founder Jim Ayres.  He continues, “The problem of obesity and the growth of health concerns such as diabetes, hypertension, and other ailments is not isolated to the US.  This is a big step for Innutra’s global expansion efforts to change the world.”  
 

Innutra, providing innovative nutrition and sustainable weight loss products, that are easy to use and very effective.  Look for big changes overseas with Innutra’s life changing nutritional products.
Innutra will have more announcements as they enter the pre-launch phase for recruiting and building the distributor force in the EU.

Read more...

‘Herbalife Will Strike A Deal With FTC’

 
Herbalife Ltd. (NYSE:HLF) bull Tim Ramey is back in the saddle again, this time at Pivotal Research. Unsurprisingly, he’s covering the nutritional supplements company again, and he’s initiated coverage with aBuy rating. The analyst has set a $110 per share price target on Herbalife.
He also says he’s expecting the company to make a deal with the Federal Trade Commission and that it will be so good for it that shares will skyrocket as a result.
Herbalife as “alpha”
Ramey remains just as bullish on Herbalife as ever. In his report dated Oct. 20, 2014, the analysts said Herbalife Ltd. (NYSE:HLF) is the best “example of ‘alpha’ in the stock market today.” Although his 12 to 18 month price target is $110, he expects Herbalife shares to climb to between $150 and $200 in the long term.
He calls the recent pullback in Herbalife stock “déjà vu,” suggesting that the company’s miss of 2 cents per share isn’t a big deal. He notes that when activist investor Bill Ackman thought he had finally dealt the “death blow” to Herbalife, investors weren’t impressed, and shares climbed 25%. Because of this increase, he suggests that investors shouldn’t worry about a small miss of 2 cents per share.
Herbalife’s growth has slowed
Ramey does point

Read more...